| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 669888 | Null | 0.0489393809599837 | 0.13176317 |
| NSC 670664 | Null | 0.0489393809599837 | 0.25176214 |
| NSC 672215 | Null | 0.0489393809599837 | 0.36830365 |
| NSC 677598 | Glutamamide, N-acetyl-1-O-(phenylmethyl)-.alpha.-normuramyl-prolyl- N(5)-[5-[(1-nitro-9-acridinyl)amino]pentyl]-, stereoisomer | 0.0489393809599837 | -0.071009375 |
| NSC 677672 | Null | 0.0489393809599837 | 0.17283031 |
| NSC 678355 | L-LYS-L-p-NO2Phe-L-Ala-L-p-NO2PheNH2 | 0.0489393809599837 | 0.19167015 |
| NSC 678925 | 1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride | 0.0489393809599837 | 0.5024523 |
| NSC 679001 | 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- | 0.0489393809599837 | 0.34496772 |
| NSC 681636 | Camptothecin Derivative | 0.0489393809599837 | 0.48248388 |
| NSC 682011 | Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- | 0.0489393809599837 | 0.15167307 |